LENZKEN, SILVIA CAROLINA
 Distribuzione geografica
Continente #
EU - Europa 180
NA - Nord America 180
AS - Asia 132
SA - Sud America 4
OC - Oceania 1
Totale 497
Nazione #
US - Stati Uniti d'America 179
CN - Cina 117
IE - Irlanda 59
UA - Ucraina 38
DE - Germania 22
FI - Finlandia 22
IT - Italia 18
SG - Singapore 14
GB - Regno Unito 11
FR - Francia 6
BR - Brasile 4
CH - Svizzera 3
BE - Belgio 1
CA - Canada 1
JP - Giappone 1
NZ - Nuova Zelanda 1
Totale 497
Città #
Dublin 59
Chandler 45
Jacksonville 42
Nanjing 33
Beijing 21
Nanchang 17
Boardman 14
Singapore 11
Princeton 10
Rodano 10
Ashburn 9
Hebei 9
Lawrence 8
Shanghai 8
Shenyang 7
Changsha 6
Helsinki 6
Medford 6
Tianjin 6
Wilmington 5
Jiaxing 4
London 4
Sao Joao da Boa Vista 4
Milan 3
Zurich 3
Jinan 2
Auckland 1
Brussels 1
Changchun 1
Dallas 1
Dearborn 1
Des Moines 1
Hangzhou 1
Los Angeles 1
Munich 1
Ningbo 1
Norwalk 1
Pavia 1
Seattle 1
Toronto 1
Woodbridge 1
Totale 367
Nome #
A novel pathway based on the recruitment of casein kinase 2 is involved in APP processing following cholinergic stimulation. 75
Role of b-amyloid in the pathophysiology of Alzheimer’s disease and cholinesterase inhibition: facing the biological complexity to treat the disease. 71
Nicotinic component of galantamine in the regulation of amyloid precursor protein processing 70
COGNITION ENHANCERS BETWEEN TREATING AND DOPING THE MIND 66
APP processing: some details of downstream cholinergic stimulation. 63
The Search For Disease Modifying Drugs For Neurodegenerative Disorders 55
Galantamina: il farmaco e il contesto 53
Development of the first Gateway firefly luciferase vector and use of reverse transcriptase in FLOE (Fluorescently Labeled Oligonucleotide Extension) reactions. 49
Totale 502
Categoria #
all - tutte 1.903
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.903


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202037 0 0 0 0 0 0 1 8 0 19 9 0
2020/202148 7 6 0 7 0 7 0 7 0 7 7 0
2021/202225 0 0 0 0 0 0 0 3 0 0 4 18
2022/2023140 13 15 0 8 16 13 0 5 64 1 5 0
2023/202442 7 5 0 3 5 7 0 5 1 6 2 1
2024/202535 3 9 4 7 0 12 0 0 0 0 0 0
Totale 502